Molbio Diagnostics Ltd vs Poly Medicure Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 23, 2026

Key Highlights

The Latest Trading Price of Molbio Diagnostics Ltd is ₹ 1237 as of 23 Oct 15:30 . The P/E Ratio of Molbio Diagnostics Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Poly Medicure Ltd changed from 57.7 on March 2021 to 37.5 on March 2026 . This represents a CAGR of -6.93% over 6 years The Market Cap of Molbio Diagnostics Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Poly Medicure Ltd changed from ₹ 7839 crore on March 2021 to ₹ 12069 crore on March 2026 . This represents a CAGR of 7.46% over 6 years The revenue of Molbio Diagnostics Ltd for the Jun '26 is ₹ 411.48 crore as compare to the Mar '26 revenue of ₹ 565.41 crore. This represent the decline of -27.22% The revenue of Poly Medicure Ltd for the Jun '26 is ₹ 560.34 crore as compare to the Mar '26 revenue of ₹ 553.98 crore. This represent the growth of 1.15% The ebitda of Molbio Diagnostics Ltd for the Jun '26 is ₹ 103.68 crore as compare to the Mar '26 ebitda of ₹ 163.51 crore. This represent the decline of -36.59% The ebitda of Poly Medicure Ltd for the Jun '26 is ₹ 160.06 crore as compare to the Mar '26 ebitda of ₹ 129.86 crore. This represent the growth of 23.26% The net profit of Molbio Diagnostics Ltd changed from ₹ -23.94 crore to ₹ 52.74 crore over 5 quarters. This represents a CAGR of NaN% The net profit of Poly Medicure Ltd changed from ₹ 74.04 crore to ₹ 85.27 crore over 9 quarters. This represents a CAGR of 6.48% The Dividend Payout of Molbio Diagnostics Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Poly Medicure Ltd changed from 18.51 % on March 2021 to 10.56 % on March 2026 . This represents a CAGR of -8.93% over 6 years .

About Molbio Diagnostics Ltd

Molbio Diagnostics Limited was originally incorporated as Molbio Diagnostics Private Limited' at Panaji, as a private company dated October 20, 2000.
Thereafter, Company was converted from a private limited company to a public limited company, and the name of Company was changed to Molbio Diagnostics Limited, and a fresh certificate of incorporation dated January 16, 2025 was issued to Company by the RoC. Company is innovative point-of-care (POC) diagnostics company focused on expanding access to accurate, rapid and cost-effective healthcare technologies to diagnose infectious and non-communicable diseases.
The Company entered into a joint venture agreement in August, 2011 with Bigtec Innovations Private Limited and Bigtec Private Limited, which started operations in 2000.
Bigtec Innovations Private Limited got merged with the Company in 2015.

About Poly Medicure Ltd

Poly Medicure Limited was incorporated on March 30, 1995.
The Company is a producer of Medical Devices.
It manufactures and supply, a diverse portfolio of medical devices in the product verticals of infusion therapy, oncology, anesthesia and respiratory care, urology, gastroenterology, blood management and blood collection, surgery and wound drainage, dialysis, central venous access catheters, veterinary medical devices and others. The Company's product portfolio comprises of more than 130 SKUs of medical devices in the product verticals of infusion therapy, oncology, anesthesia and respiratory care, urology, gastroenterology, blood management and blood collection, surgery and wound drainage, dialysis, central venous access catheters, veterinary medical devices, and others.
It currently operate 10 manufacturing facilities across India, China, Egypt and Italy.

FAQs for the comparison of null and Poly Medicure Ltd

Which company has a larger market capitalization, Molbio Diagnostics Ltd or Poly Medicure Ltd?

Market cap of Molbio Diagnostics Ltd is 14,262 Cr while Market cap of Poly Medicure Ltd is 14,628 Cr

What are the key factors driving the stock performance of Molbio Diagnostics Ltd and Poly Medicure Ltd?

The stock performance of Molbio Diagnostics Ltd and Poly Medicure Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Molbio Diagnostics Ltd and Poly Medicure Ltd?

As of October 23, 2026, the Molbio Diagnostics Ltd stock price is INR ₹1237.65. On the other hand, Poly Medicure Ltd stock price is INR ₹1443.2.

How do dividend payouts of Molbio Diagnostics Ltd and Poly Medicure Ltd compare?

To compare the dividend payouts of Molbio Diagnostics Ltd and Poly Medicure Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.